Cargando…

2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?

BACKGROUND AND AIM: Seasonal influenza exerts a deep and multi-level impact on population and public health systems. Among at risk groups, healthcare workers (HCWs) represent a crucial one due to the threat of absenteeism and consequent disruption of healthcare services (and economic losses). Also i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecce, Maurizio, Perrone, Pier Mario, Bonalumi, Federica, Castaldi, Silvana, Cremonesi, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851003/
https://www.ncbi.nlm.nih.gov/pubmed/34739469
http://dx.doi.org/10.23750/abm.v92iS6.12230
_version_ 1784652735528828928
author Lecce, Maurizio
Perrone, Pier Mario
Bonalumi, Federica
Castaldi, Silvana
Cremonesi, Monica
author_facet Lecce, Maurizio
Perrone, Pier Mario
Bonalumi, Federica
Castaldi, Silvana
Cremonesi, Monica
author_sort Lecce, Maurizio
collection PubMed
description BACKGROUND AND AIM: Seasonal influenza exerts a deep and multi-level impact on population and public health systems. Among at risk groups, healthcare workers (HCWs) represent a crucial one due to the threat of absenteeism and consequent disruption of healthcare services (and economic losses). Also in this group vaccine hesitancy is a well known issue, therefore innovative and 360-degree strategies are urgently needed to overcome the problem. METHODS: in the 2020-21 influenza vaccination campaign in a research and teaching hospital in Milan, Italy, the working group implemented three different strategies: the offer of vaccination through both an ad hoc ambulatory and several itinerant (on site) vaccinating teams, a promotional and educational communication campaign, a gaming strategy. RESULTS: vaccinated employees nearly doubled (2103 vs 1153 in 2019-20 flu vaccination campaign), reaching a comprehensive vaccination coverage rate (VCR) of 43,1%. A highly significant increase in the 40-59 age group was registered. While physicians and nursing staff confirmed to be the most represented categories among vaccinated subjects, administrative and auxiliary staffs performed the greatest increase compared to the previous campaign. The on site vaccination was clearly preferred than the ad hoc one (1693 HCWs, 80,5% vs 410, 19,5%). Vaccinated for the first time registered a significant increase (40,2% vs 36,2% in 2019-20 campaign). CONCLUSIONS: such meaningful results confirm the effectiveness of the strategies implemented in the present campaign, suggesting their possible application in the debated COVID19-third-dose vaccination campaign. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-8851003
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-88510032022-02-28 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose? Lecce, Maurizio Perrone, Pier Mario Bonalumi, Federica Castaldi, Silvana Cremonesi, Monica Acta Biomed Original Investigations/Commentaries BACKGROUND AND AIM: Seasonal influenza exerts a deep and multi-level impact on population and public health systems. Among at risk groups, healthcare workers (HCWs) represent a crucial one due to the threat of absenteeism and consequent disruption of healthcare services (and economic losses). Also in this group vaccine hesitancy is a well known issue, therefore innovative and 360-degree strategies are urgently needed to overcome the problem. METHODS: in the 2020-21 influenza vaccination campaign in a research and teaching hospital in Milan, Italy, the working group implemented three different strategies: the offer of vaccination through both an ad hoc ambulatory and several itinerant (on site) vaccinating teams, a promotional and educational communication campaign, a gaming strategy. RESULTS: vaccinated employees nearly doubled (2103 vs 1153 in 2019-20 flu vaccination campaign), reaching a comprehensive vaccination coverage rate (VCR) of 43,1%. A highly significant increase in the 40-59 age group was registered. While physicians and nursing staff confirmed to be the most represented categories among vaccinated subjects, administrative and auxiliary staffs performed the greatest increase compared to the previous campaign. The on site vaccination was clearly preferred than the ad hoc one (1693 HCWs, 80,5% vs 410, 19,5%). Vaccinated for the first time registered a significant increase (40,2% vs 36,2% in 2019-20 campaign). CONCLUSIONS: such meaningful results confirm the effectiveness of the strategies implemented in the present campaign, suggesting their possible application in the debated COVID19-third-dose vaccination campaign. (www.actabiomedica.it) Mattioli 1885 2021 2021-10-01 /pmc/articles/PMC8851003/ /pubmed/34739469 http://dx.doi.org/10.23750/abm.v92iS6.12230 Text en Copyright: © 2021 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Investigations/Commentaries
Lecce, Maurizio
Perrone, Pier Mario
Bonalumi, Federica
Castaldi, Silvana
Cremonesi, Monica
2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title_full 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title_fullStr 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title_full_unstemmed 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title_short 2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
title_sort 2020-21 influenza vaccination campaign strategy as a model for the third covid-19 vaccine dose?
topic Original Investigations/Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851003/
https://www.ncbi.nlm.nih.gov/pubmed/34739469
http://dx.doi.org/10.23750/abm.v92iS6.12230
work_keys_str_mv AT leccemaurizio 202021influenzavaccinationcampaignstrategyasamodelforthethirdcovid19vaccinedose
AT perronepiermario 202021influenzavaccinationcampaignstrategyasamodelforthethirdcovid19vaccinedose
AT bonalumifederica 202021influenzavaccinationcampaignstrategyasamodelforthethirdcovid19vaccinedose
AT castaldisilvana 202021influenzavaccinationcampaignstrategyasamodelforthethirdcovid19vaccinedose
AT cremonesimonica 202021influenzavaccinationcampaignstrategyasamodelforthethirdcovid19vaccinedose